Who Buys Vildagliptin from India — 304 Importers Behind a $10.2M Market

The 304 buyers of Vildagliptin imported from India can be categorized into several segments:

1. Pharmaceutical Distributors: Entities like PLANET PHARMA SA in France and TECNIMEDE SOCIEDADE TECNICO MEDICIN in Portugal fall into this category. These distributors procure Vildagliptin in bulk to supply to various healthcare providers, including pharmacies and hospitals. Their purchasing patterns typically involve large, regular orders to maintain a steady supply chain.

2. Hospital Groups: Organizations such as AL HILAL PHARMACY in Yemen and EMCURE PHARMA CHILE S.P.A. in Chile represent hospital groups that import Vildagliptin directly for patient treatment. Their procurement is often based on patient demand and formulary inclusion, leading to consistent, moderate-sized orders.

3. Retail Pharmacy Chains: Entities like BROCACEF NL DUTCH in the Netherlands and PHARMACY PLUS in the Maldives are retail chains that import Vildagliptin to stock their outlets. Their buying behavior is influenced by consumer demand, resulting in frequent, smaller orders to ensure product availability without overstocking.

4. Government Procurement Agencies: While not explicitly listed among the top buyers, government agencies in various countries may engage in tender-based purchasing of Vildagliptin for public health programs. These procurements are typically large-scale and periodic, aligning with budget cycles and public health initiatives.

5. Re-exporters: Some buyers may act as intermediaries, importing Vildagliptin from India to re-export to neighboring regions. Their order patterns are opportunistic, based on market demand and trade agreements.

6. Contract Manufacturers: Companies like EMCURE PHARMA CHILE S.P.A. may also function as contract manufacturers, importing Vildagliptin for formulation and packaging before distribution. Their procurement is aligned with production schedules and contractual obligations.

For the top five importing countries of Vildagliptin from India, the import regulations are as follows:

The demand for Vildagliptin in importing countries is primarily driven by the increasing prevalence of type 2 diabetes mellitus (T2DM). According to the International Diabetes Federation, as of 2025, approximately 537 million adults worldwide are living with diabetes, with projections indicating a rise to 643 million by 2030. This escalating prevalence underscores the need for effective antidiabetic medications like Vildagliptin.

Government healthcare programs and the expansion of universal health coverage also play significant roles in driving demand. Many countries have included Vildagliptin in their national formularies, facilitating its procurement through public health initiatives and tender-based purchasing systems. Additionally, the World Health Organization's Essential Medicines List serves as a reference for countries to prioritize the procurement of vital medications, potentially influencing the inclusion of Vildagliptin in national procurement strategies.

Our data indicates that 304 buyers across 87 countries have imported Vildagliptin from India, reflecting a broad and growing market opportunity for this medication.

The 304 buyers of Vildagliptin imported from India can be categorized into several segments:

1. Pharmaceutical Distributors: Entities like PLANET PHARMA SA in France and TECNIMEDE SOCIEDADE TECNICO MEDICIN in Portugal fall into this category. These distributors procure Vildagliptin in bulk to supply to various healthcare providers, including pharmacies and hospitals. Their purchasing patterns typically involve large, regular orders to maintain a steady supply chain.

2. Hospital Groups: Organizations such as AL HILAL PHARMACY in Yemen and EMCURE PHARMA CHILE S.P.A. in Chile represent hospital groups that import Vildagliptin directly for patient treatment. Their procurement is often based on patient demand and formulary inclusion, leading to consistent, moderate-sized orders.

3. Retail Pharmacy Chains: Entities like BROCACEF NL DUTCH in the Netherlands and PHARMACY PLUS in the Maldives are retail chains that import Vildagliptin to stock their outlets. Their buying behavior is influenced by consumer demand, resulting in frequent, smaller orders to ensure product availability without overstocking.

4. Government Procurement Agencies: While not explicitly listed among the top buyers, government agencies in various countries may engage in tender-based purchasing of Vildagliptin for public health programs. These procurements are typically large-scale and periodic, aligning with budget cycles and public health initiatives.

5. Re-exporters: Some buyers may act as intermediaries, importing Vildagliptin from India to re-export to neighboring regions. Their order patterns are opportunistic, based on market demand and trade agreements.

6. Contract Manufacturers: Companies like EMCURE PHARMA CHILE S.P.A. may also function as contract manufacturers, importing Vildagliptin for formulation and packaging before distribution. Their procurement is aligned with production schedules and contractual obligations.

For the top five importing countries of Vildagliptin from India, the import regulations are as follows:

The demand for Vildagliptin in importing countries is primarily driven by the increasing prevalence of type 2 diabetes mellitus (T2DM). According to the International Diabetes Federation, as of 2025, approximately 537 million adults worldwide are living with diabetes, with projections indicating a rise to 643 million by 2030. This escalating prevalence underscores the need for effective antidiabetic medications like Vildagliptin.

Government healthcare programs and the expansion of universal health coverage also play significant roles in driving demand. Many countries have included Vildagliptin in their national formularies, facilitating its procurement through public health initiatives and tender-based purchasing systems. Additionally, the World Health Organization's Essential Medicines List serves as a reference for countries to prioritize the procurement of vital medications, potentially influencing the inclusion of Vildagliptin in national procurement strategies.

Our data indicates that 304 buyers across 87 countries have imported Vildagliptin from India, reflecting a broad and growing market opportunity for this medication.